Analysts Set Kura Oncology, Inc. (NASDAQ:KURA) Target Price at $27.69
Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has been assigned an average rating of “Moderate Buy” from the eight research firms that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year […]
More Stories
Advisors Asset Management Inc. Makes New Investment in Cencora, Inc. (NYSE:COR)
Advisors Asset Management Inc. bought a new stake in Cencora, Inc. (NYSE:COR – Free Report) during the 1st quarter, according...
Hydro One (TSE:H) Hits New 1-Year High at $42.03
Shares of Hydro One Limited (TSE:H – Get Free Report) reached a new 52-week high on Wednesday . The company...
Advisors Asset Management Inc. Increases Stock Holdings in Herc Holdings Inc. (NYSE:HRI)
Advisors Asset Management Inc. lifted its position in Herc Holdings Inc. (NYSE:HRI – Free Report) by 9.2% in the first...
Advisors Asset Management Inc. Decreases Position in Principal Financial Group, Inc. (NYSE:PFG)
Advisors Asset Management Inc. lowered its stake in shares of Principal Financial Group, Inc. (NYSE:PFG – Free Report) by 12.2%...
Shell Asset Management Co. Buys 7,728 Shares of General Motors (NYSE:GM)
Shell Asset Management Co. lifted its position in General Motors (NYSE:GM – Free Report) (TSE:GMM.U) by 27.5% during the first...
Emergent BioSolutions (NYSE:EBS) Reaches New 52-Week High at $13.23
Shares of Emergent BioSolutions Inc. (NYSE:EBS – Get Free Report) reached a new 52-week high on Wednesday . The company...